Study of Efficacy and Safety of Irbesartan/Amlodipine 4 Fixed Combination Therapy in Hypertensive Patients Uncontrolled on Irbesartan or Amlodipine Monotherapy
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 158 participants.
Also called NCT01625494
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 158 participants
- Sponsor
- Registry
-
NCT01625494
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Russia
- Registry status
- Completed
Technical summary
Registry record NCT01625494. Randomized; no masking; primary purpose treatment. Start 2012-05 (registry gives no type); primary completion 2013-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study of Efficacy and Safety of Irbesartan/Amlodipine 4 Fixed Combination Therapy in Hypertensive Patients Uncontrolled on Irbesartan or Amlodipine Monotherapy
- Condition
- Hypertension
- Intervention (Drug)
- Irbesartan/Amlodipine (150/5mg)
- Intervention (Drug)
- Irbesartan/Amlodipine (150/10mg)
- Intervention (Drug)
- Irbesartan/Amlodipine (300/5mg)
- Intervention (Drug)
- Irbesartan/Amlodipine (300/10mg)
- Lead sponsor
- Sanofi
Record details
- Record id
cardio:ct-nct01625494- Content hash
28f49200cb88c0a1609016ecfaf132648d31a923b894cc8da0b6cd2fcdbb35ec